The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional) |
93.113, 93.242, 93.273, 93.279, 93.313, 93.846, 93.847, 93.866 |
RFA-OD-19-013 |
| Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-18-022 |
| Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) |
93.855 |
PA-19-081 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) |
93.121 |
PA-19-076 |
| Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional) |
93.242, 93.307 |
RFA-MH-19-412 |
| Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R34 Clinical Trial Required) |
93.242 |
RFA-MH-19-410 |
| Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional) |
93.242, 93.307 |
RFA-MH-19-411 |
| Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-18-057 |
| Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) |
93.361 |
PA-19-073 |
| Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional) |
93.879 |
PAR-19-072 |
| Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) |
93.361 |
PA-19-074 |
| Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) |
93.121, 93.233, 93.273, 93.394, 93.395, 93.837, 93.838, 93.839, 93.865, 93.940 |
PAR-19-069 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) |
93.866 |
PAR-19-071 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
93.853, 93.866 |
PAR-19-070 |
| Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional) |
93.353, 93.399 |
RFA-CA-19-005 |
| Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) |
93.273 |
RFA-AA-19-005 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-19-009 |
| Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-19-008 |
| Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional) |
93.353, 93.399 |
RFA-CA-19-006 |
| Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) |
93.855 |
PA-19-068 |
| Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed) |
93.286, 93.847 |
PA-19-065 |
| Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
93.855 |
PA-19-066 |
| Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed) |
93.242, 93.855 |
RFA-AI-18-053 |
| Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
93.855 |
PA-19-067 |
| Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) |
93.172 |
PAR-19-061 |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
93.279 |
PAR-19-064 |
| Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-18-010 |
| NINR Clinical Trial Planning Grant (R34 Clinical Trial Required) |
93.361 |
PAR-19-060 |
| Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional) |
93.113, 93.213, 93.242, 93.307, 93.313, 93.321, 93.867 |
PAR-19-059 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
93.361 |
PAR-19-057 |
| Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
93.361 |
PAR-19-058 |
| Collaborative Study on the Genetics of Alcoholism (COGA) (Clinical Trial Not Allowed U10) |
93.273 |
RFA-AA-19-001 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
93.113, 93.172, 93.242, 93.279, 93.286, 93.307, 93.853, 93.855, 93.866 |
PA-19-052 |
| Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.351, 93.361, 93.393, 93.394, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.879 |
PA-19-056 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
93.113, 93.172, 93.173, 93.273, 93.279, 93.307, 93.361, 93.846, 93.855, 93.866 |
PA-19-054 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.273, 93.279, 93.307, 93.361, 93.846, 93.855, 93.866, 93.867, 93.879 |
PA-19-053 |
| Research Project Grant (Parent R01 Clinical Trial Required) |
93.113, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867 |
PA-19-055 |
| Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.279, 93.313, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-19-010 |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
93.113, 93.121, 93.172, 93.242, 93.313, 93.398, 93.853, 93.989 |
PAR-19-051 |
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-004 |
Search Results 3881-3920 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
